Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review
Clinical Genetics · 2026-12 · 110 (6) · 647-685
DOI: 10.1111/cge.70249 ↗Kurz gefasst
Scoping Review in der Zeitschrift Clinical Genetics, online erschienen am 25.09.2026. Verfasst von Tessa Robinson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Prevention & Screening, Population and Community-Based Care, Ontario Health, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Early Detection of Cancer, Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Care Ontario.
Abstract (Originalsprache)
Liquid biopsy constitutes a range of tests that use biological fluids to detect cancer. Research is now targeting their use for cancer screening. This is the first review of the evidence on liquid biopsy tests across a range of analytical parameters, biomarkers, and cancer types for cancer screening. A scoping review was conducted using JBI methodology for scoping reviews. MEDLINE and targeted websites were searched for studies published in 2014 or later on the use of liquid biopsy and multi‐cancer early detection tests for screening. A total of 104 studies were included, covering a wide range of study designs. Several types of biomarkers (e.g., cell‐free DNA, circulating tumor DNA) and analytical parameters were used. Most studies addressed test performance outcomes, while fewer addressed clinical outcomes, implementation considerations, and cost‐effectiveness. No empirical studies on cancer‐specific mortality were found. A large body of literature was identified that covered a range of cancer types, biomarkers, analytical parameters, and outcomes. Critical gaps in the literature were demonstrated, including evidence on clinical outcomes such as cancer‐specific mortality and potential harms that currently preclude the implementation of liquid biopsy tests for cancer screening. Findings of this review can be used to guide the necessary future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Prevention & Screening, Population and Community-Based Care, Ontario Health, Toronto, Ontario, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Tessa Robinson, Lily Thao Nguyen, Olivia Meggetto, Jill Tinmouth, Meghan J Walker
Förderung
- Cancer Care Ontario
Zitieren
APA
Robinson, T., Saab, M., Nguyen, L. T., Kochar, P., Meggetto, O., Tinmouth, J., & Walker, M. J. (2026). Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review. Clinical Genetics, 110(6), 647-685. https://doi.org/10.1111/cge.70249
Vancouver
Robinson T, Saab M, Nguyen LT, Kochar P, Meggetto O, Tinmouth J, et al. Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review. Clinical Genetics. 2026;110(6):647-685. doi:10.1111/cge.70249
BibTeX
@article{Robinson2026,
author = {Robinson, Tessa and Saab, Marian and Nguyen, Lily Thao and Kochar, Pooja and Meggetto, Olivia and Tinmouth, Jill and Walker, Meghan J},
title = {Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {6},
pages = {647--685},
doi = {10.1111/cge.70249}
}
EUVIMED